Bristol clobbered—shares drop 17%—after failed drug test

August 5, 2016 2:45 PM

19 0

Bristol clobbered—shares drop 17%—after failed drug test

Shares of Bristol-Myers Squibb plunged more than 17 percent in morning trading Friday after its important cancer drug failed to meet targets in a late-stage study.

Shares of Bristol-Myers' competitors who have their own versions of the cancer therapy rose on the news.

Also read: Murdoch's Twenty-First Century Fox Bids $14 Billion For UK's Sky

Read more

To category page

Loading...